NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Faes Farma S.A (MC: FAE)

 
FAE Technical Analysis
5
As on 28th Mar 2025 FAE STOCK Price closed @ 4.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.31 & Strong Buy for SHORT-TERM with Stoploss of 3.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

FAESTOCK Price

Open 4.02 Change Price %
High 4.07 1 Day -0.02 -0.50
Low 3.95 1 Week 0.67 20.12
Close 4.00 1 Month 0.34 9.29
Volume 459580 1 Year 1.02 34.23
52 Week High 3.90 | 52 Week Low 2.88
 
MC Spain Most Active Stocks
SAN 6.32 -2.02%
SAB 2.59 -2.26%
UBS 0.00 %
IBE 15.02 2.04%
BBVA 12.72 -3.27%
TEF 4.32 -0.23%
BKY 0.32 0.00%
IAG 3.34 -4.30%
EZE 0.12 %
CABK 7.26 -1.36%
 
MC Spain Top Gainers Stocks
GCO 49.05 16.09%
GCO 49.05 16.09%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
 
MC Spain Top Losers Stocks
CDR 0.09 -30.77%
CDR 0.09 -30.77%
CDR 0.09 -30.77%
CDR 0.09 -30.77%
MED 0.69 -19.77%
MED 0.69 -19.77%
MED 0.69 -19.77%
MED 0.69 -19.77%
MED 0.69 -19.77%
MED 0.69 -19.77%
 
 
FAE
Daily Charts
FAE
Intraday Charts
Whats New @
Bazaartrend
FAE
Free Analysis
 
FAE Important Levels Intraday
RESISTANCE4.23
RESISTANCE4.16
RESISTANCE4.11
RESISTANCE4.07
SUPPORT3.93
SUPPORT3.89
SUPPORT3.84
SUPPORT3.77
 
FAE Forecast March 2025
4th UP Forecast4.52
3rd UP Forecast4.35
2nd UP Forecast4.25
1st UP Forecast4.15
1st DOWN Forecast3.85
2nd DOWN Forecast3.75
3rd DOWN Forecast3.65
4th DOWN Forecast3.48
 
FAE Weekly Forecast
4th UP Forecast4.29
3rd UP Forecast4.20
2nd UP Forecast4.14
1st UP Forecast4.08
1st DOWN Forecast3.92
2nd DOWN Forecast3.86
3rd DOWN Forecast3.80
4th DOWN Forecast3.71
 
FAE Forecast2025
4th UP Forecast6.31
3rd UP Forecast5.57
2nd UP Forecast5.11
1st UP Forecast4.65
1st DOWN Forecast3.35
2nd DOWN Forecast2.89
3rd DOWN Forecast2.43
4th DOWN Forecast1.69
 
 
FAE Other Details
Segment EQ
Market Capital 1020962304.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
FAE Address
FAE
 
FAE Latest News
 
Your Comments and Response on Faes Farma S.A
 
FAE Business Profile
Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter (OTC) drugs, food supplements, baby foods, and other health products. It offers Actimag, a magnesium pidolate; Bilaxten, an anti-allergic; Bronquidiazina CR, an anti-infective; Claversal for ulcerative colitis and Crohn's disease; Dezacor, a corticoid; Dolotren, an anti-inflammatory; Dolotren Gel; Dynamogen, an anti-anorexic; Ferroprotina, an anti-anaemic; Hidroferol; Lipofen; Positon for dermatitis; strength builder products, such as Potenciator and Surmenalit; Pruina, a laxative; Robaxisal Compuesto, a muscle relaxant and analgesic; Trausan, a citicoline; Venosmil, a venous vasoprotector; Venosmil Gel; and Yendol, an anti-flu. The company also provides Bilastine, an antihistamine molecule for the treatment of allergic rhino conjunctivitis and urticarial; Calcifediol for bone metabolism; Deflazacort to treat osteoarticular disease; Hidrosmin for venous insufficiency; and Mesalazine to treat digestion problems. It also exports its products. Faes Farma, S.A. was founded in 1933 and is headquartered in Leioa, Spain. Address: Avenida Autonomía 10, Leioa, Spain, 48940
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service